🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK1070806 is a humanised IgG1/kappa antibody which is directed against the...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08
Trial ID
NCT01648153
Treatments Being Tested
This study is parallel group, placebo-controlled dose-ranging study to eval...
Status
Terminated
Location
GSK Investigational Site
Start Date
2023-11-16
Trial ID
NCT05999799
Treatments Being Tested
The study is designed to evaluate the long-term safety and efficacy of GSK1...
Status
Terminated
Location
GSK Investigational Site
Start Date
2024-06-05
Trial ID
NCT06447506
Treatments Being Tested
GSK1070806 is a humanised monoclonal antibody that blocks a protein present...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01-05
Trial ID
NCT01035645
Treatments Being Tested
This is a phase 2 study to evaluate the efficacy, safety, tolerability and ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2016-08-27
Trial ID
NCT02723786
This study will evaluate efficacy and safety of GSK1070806 in moderate to s...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-11-18
Trial ID
NCT04975438
Treatments Being Tested
This goal of this sub-study is to learn how safe and tolerable the study dr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-10
Trial ID
NCT07747480
Treatments Being Tested
This study is divided into two parts: Part A of the study is double blinde...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-11-04
Trial ID
NCT05590338
Treatments Being Tested
The primary outcome measure of the study is to demonstrate the safety and t...
Status
Unknown
Location
Addenbrooke's Hospital, University of Cambridge NHS Foundation Trust
Start Date
2018-08-01
Trial ID
NCT03522662
Treatments Being Tested
This study will look at how safe and tolerable different treatments are for...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-10
Trial ID
NCT07747467
Treatments Being Tested